Literature DB >> 1379045

Concurrent down-regulation of IP prostanoid receptors and the alpha-subunit of the stimulatory guanine-nucleotide-binding protein (Gs) during prolonged exposure of neuroblastoma x glioma cells to prostanoid agonists. Quantification and functional implications.

E J Adie1, I Mullaney, F R McKenzie, G Milligan.   

Abstract

Neuroblastoma x glioma hybrid NG108-15 cells express a high-affinity IP prostanoid receptor. Saturation binding analysis of this receptor, using [3H]prostaglandin E1 ([3H]PGE1) as ligand, indicated that it was present at some 1.5 pmol/mg of membrane protein and displayed a dissociation constant for this ligand of 30-40 nM. Prolonged exposure of these cells either to PGE1 or to iloprost, which is a stable analogue of prostacyclin, caused a 40-70% decrease in levels of the receptor. The remaining receptors were capable of interacting with the stimulatory G-protein (Gs) of the adenylate cyclase cascade, as saturation analysis of the binding of [3H]PGE1 indicated that they had a similar affinity for the 3H-labelled ligand, and because the specific binding of [3H]PGE1 to these receptors was still sensitive to the presence of poorly hydrolysed analogues of GTP. We have recently demonstrated that prolonged exposure of NG108-15 ells to PGE1 causes a cyclic AMP-independent loss of Gs alpha-subunit (Gs alpha) from these cells [McKenzie & Milligan (1990) J. Biol. Chem. 265, 17084-17093]. Steady-state concentration of the larger 45 kDa form of Gs alpha (which is the predominant form expressed in these cells) was assessed to be 9.6 pmol/mg of membrane protein, and treatment with iloprost decreased levels of this polypeptide to some 3.0 pmol/mg of protein. Time courses of iloprost-mediated down-regulation of the IP prostanoid receptor, loss of Gs alpha protein as assessed by immunoblotting and loss of Gs alpha activity as assessed by the reconstitution of NaF stimulation of adenylate cyclase activity to membranes of S49 cyc- cells by sodium cholate extracts of NG108-15 cells were identical, suggesting that the loss of the IP prostanoid receptor and G-protein occurred in parallel. Each of these effects was half-maximal between 2 and 3 h of exposure to the agonist. Stoichiometry of loss of Gs alpha and IP prostanoid receptor was unchanged by the percentage receptor occupancy, and quantification indicated the loss of some 7-10 mol of Gs alpha/mol of receptor. This is the first report to demonstrate the temporal concurrence of loss of Gs alpha and of a receptor which interacts with this G-protein. Chronic activation of the IP prostanoid receptor on these cells results in the development of a heterologous form of desensitization to agents which function to activate adenylate cyclase [Kelly, Keen, Nobbs & MacDermot (1990) Br. J. Pharmacol. 99, 306-316]. Agonist regulation of Gs alpha levels in these cells may contribute to this process.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379045      PMCID: PMC1132820          DOI: 10.1042/bj2850529

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

Review 1.  Agonist control of G-protein levels.

Authors:  G Milligan; A Green
Journal:  Trends Pharmacol Sci       Date:  1991-06       Impact factor: 14.819

2.  Down-regulation of Gi sub-types by prolonged incubation of adipocytes with an A1 adenosine receptor agonist.

Authors:  A Green; J L Johnson; G Milligan
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

3.  Delta-opioid-receptor-mediated inhibition of adenylate cyclase is transduced specifically by the guanine-nucleotide-binding protein Gi2.

Authors:  F R McKenzie; G Milligan
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

4.  Foetal-calf serum stimulates a pertussis-toxin-sensitive high-affinity GTPase activity in rat glioma C6 BU1 cells.

Authors:  G Milligan
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

5.  Guanine-nucleotide-binding proteins expressed in rat white adipose tissue. Identification of both mRNAs and proteins corresponding to Gi1, Gi2 and Gi3.

Authors:  F M Mitchell; S L Griffiths; E D Saggerson; M D Houslay; J T Knowler; G Milligan
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

6.  Desensitization of adenylate cyclase to prostaglandin E1 or 2-chloroadenosine.

Authors:  J G Kenimer; M Nirenberg
Journal:  Mol Pharmacol       Date:  1981-11       Impact factor: 4.436

7.  Segregation of discrete GS alpha-mediated responses that accompany homologous or heterologous desensitization in two related somatic hybrids.

Authors:  E Kelly; M Keen; P Nobbs; J MacDermot
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

8.  Increase in Gs and cyclic AMP generation in HIT cells. Evidence that the 45-kDa alpha-subunit of Gs has greater functional activity than the 52-kDa alpha-subunit.

Authors:  T F Walseth; H J Zhang; L K Olson; W A Schroeder; R P Robertson
Journal:  J Biol Chem       Date:  1989-12-15       Impact factor: 5.157

9.  Ethanol increases extracellular adenosine by inhibiting adenosine uptake via the nucleoside transporter.

Authors:  L E Nagy; I Diamond; D J Casso; C Franklin; A S Gordon
Journal:  J Biol Chem       Date:  1990-02-05       Impact factor: 5.157

10.  Chronic ethanol causes heterologous desensitization of receptors by reducing alpha s messenger RNA.

Authors:  D Mochly-Rosen; F H Chang; L Cheever; M Kim; I Diamond; A S Gordon
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

View more
  16 in total

1.  Internalization and down-regulation of the prostacyclin receptor in human platelets.

Authors:  S Giovanazzi; M R Accomazzo; O Letari; D Oliva; S Nicosia
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Detection and analysis of agonist-induced formation of the complex of the stimulatory guanine nucleotide-binding protein with adenylate cyclase in intact wild-type and beta 2-adrenoceptor-expressing NG108-15 cells.

Authors:  G D Kim; I C Carr; G Milligan
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

3.  Muscarinic acetylcholine receptor down-regulation limits the extent of inhibition of cell cycle progression in Chinese hamster ovary cells.

Authors:  K Detjen; J Yang; C D Logsdon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

4.  Enhanced degradation of the phosphoinositidase C-linked guanine-nucleotide-binding protein Gq alpha/G11 alpha following activation of the human M1 muscarinic acetylcholine receptor expressed in CHO cells.

Authors:  F M Mitchell; N J Buckley; G Milligan
Journal:  Biochem J       Date:  1993-07-15       Impact factor: 3.857

5.  Prostanoid receptors involved in the relaxation of human bronchial preparations.

Authors:  X Norel; L Walch; C Labat; J P Gascard; E Dulmet; C Brink
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

6.  Prostanoid receptors involved in the relaxation of human pulmonary vessels.

Authors:  L Walch; C Labat; J P Gascard; V de Montpreville; C Brink; X Norel
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

7.  Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients.

Authors:  R Stratton; X Shiwen; G Martini; A Holmes; A Leask; T Haberberger; G R Martin; C M Black; D Abraham
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

8.  ONO-54918-07, a stable prostacyclin analogue, mimics the effect of prostaglandin PGE1 on NG108-15 cells.

Authors:  Adolfo Cavalié; Stephan Ernst Philipp; Hans Meves
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-10-19       Impact factor: 3.000

9.  The action of prostaglandins on ion channels.

Authors:  Hans Meves
Journal:  Curr Neuropharmacol       Date:  2006-01       Impact factor: 7.363

10.  Regulation of cellular Gs alpha levels and basal adenylyl cyclase activity by expression of the beta 2-adrenoceptor in neuroblastoma cell lines.

Authors:  G Milligan; G D Kim; I Mullaney; E J Adie
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.